Welcoming the Era of Gene Editing in Medicine
New England Journal of Medicine · 2024
DOI: 10.1056/nejmp2314279 ↗Kurz gefasst
Fachartikel in der Zeitschrift New England Journal of Medicine, 2024. Verfasst von George Q Daley. Beteiligte Einrichtung: From Boston Children's Hospital and Harvard Medical School - both in Boston. Hauptthemen laut MEDLINE: Anemia, Sickle Cell, CRISPR-Cas Systems, Gene Editing, Genetic Therapy. Die Arbeit wurde bisher 25-mal zitiert (Crossref) und nennt 5 Literaturangaben.
Abstract (Originalsprache)
Recent approvals of exa-cel for treatment of sickle cell disease and transfusion-dependent β-thalassemia mark the dawn of the era of gene editing in medicine. But ensuring access will be challenging.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- From Boston Children's Hospital and Harvard Medical School - both in Boston.
Zitieren
APA
Daley, G. Q. (2024). Welcoming the Era of Gene Editing in Medicine. New England Journal of Medicine. https://doi.org/10.1056/nejmp2314279
Vancouver
Daley GQ. Welcoming the Era of Gene Editing in Medicine. New England Journal of Medicine. 2024. doi:10.1056/nejmp2314279
BibTeX
@article{Daley2024,
author = {Daley, George Q},
title = {Welcoming the Era of Gene Editing in Medicine},
journal = {New England Journal of Medicine},
year = {2024},
doi = {10.1056/nejmp2314279}
}
EUVIMED